VP, CMC and Supply Chain @ (January 2024 - May 2026)
VP CMC @ (March 2021 - May 2026)
Head of Process Chemistry @ (July 2020 - March 2021)
Owner and Principal Consultant @ (October 2019 - March 2021)
CMC Manufacturing Head @ (February 2019 - December 2019)
Senior Director, Process Chemistry @ (April 2017 - February 2019)
Director of Chemical Development @ (December 2014 - March 2017)
Director of Process Chemistry @ (April 2014 - October 2014)
Director of Chemical Development @ (December 2011 - April 2014)
Senior Director, Chemistry and Biology @ (November 2005 - January 2011)
Group (Executive) Director, Lead Discovery and Head of Operations @ (January 1999 - January 2005)
Associate Director @ Texas Biotechnology Corporation (January 1992 - January 1999)
Post Doctoral Student @ (March 1989 - September 1992)
Ian Scott Education
The University of Sheffield
PhD (Chemistry)
1986-1989
The University of Sheffield
M.Phil (Chemistry)
1985-1987
The University of Sheffield
BSc (Chemistry)
1982-1985
Ian Scott Skills
Clinical Trials
Drug Design
Public Speaking
CRO
Chemistry
Neurodegeneration
GMP
Neuroscience
Biotechnology
Cell
Regulatory Affairs
Process Improvement
Drug Discovery
Research And Development R&D
CRO Management
Oncology
Drug Development
Clinical Development
Cancer
Medicinal Chemistry
Management
Pharmaceutical Industry
Technology Transfer
Toxicology
R&D
Microsoft Excel
Microsoft Office
Marketing
Research
Project Management
Teaching
Business Development
Research and Development
Ian Scott Summary
Ian Scott, based in Denver, CO, US, is currently a Sr. VP CMC and Supply Chain at Enliven Therapeutics. Ian Scott brings experience from previous roles at Enliven Therapeutics, Zentalis Pharmaceuticals and Chemelian. Ian Scott holds a 1986 - 1989 PhD in Chemistry @ The University of Sheffield. With a robust skill set that includes Clinical Trials, Drug Design, Public Speaking, CRO, Chemistry and more. Ian Scott has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Ian Scott?
Find contact details for 700 million professionals.